These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29261720)

  • 1. A mutant of phosphomannomutase1 retains full enzymatic activity, but is not activated by IMP: Possible implications for the disease PMM2-CDG.
    Citro V; Cimmaruta C; Liguori L; Viscido G; Cubellis MV; Andreotti G
    PLoS One; 2017; 12(12):e0189629. PubMed ID: 29261720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effects of PMM2-CDG-Causing Mutations on the Folding, Activity, and Stability of the PMM2 Protein.
    Yuste-Checa P; Gámez A; Brasil S; Desviat LR; Ugarte M; Pérez-Cerdá C; Pérez B
    Hum Mutat; 2015 Sep; 36(9):851-60. PubMed ID: 26014514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A zebrafish model of PMM2-CDG reveals altered neurogenesis and a substrate-accumulation mechanism for N-linked glycosylation deficiency.
    Cline A; Gao N; Flanagan-Steet H; Sharma V; Rosa S; Sonon R; Azadi P; Sadler KC; Freeze HH; Lehrman MA; Steet R
    Mol Biol Cell; 2012 Nov; 23(21):4175-87. PubMed ID: 22956764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Glucose-1,6-Bisphosphate Stabilizes Pathological Phophomannomutase2 Mutants In Vitro and Represents a Lead Compound to Develop Pharmacological Chaperones for the Most Common Disorder of Glycosylation, PMM2-CDG.
    Monticelli M; Liguori L; Allocca M; Andreotti G; Cubellis MV
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31454904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring ligand interactions with human phosphomannomutases using recombinant bacterial thermal shift assay and biochemical validation.
    Monticelli M; Hay Mele B; Wright DM; Guerriero S; Andreotti G; Cubellis MV
    Biochimie; 2024 Jul; 222():123-131. PubMed ID: 38458414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Analysis of Variants in the General Population Reveals That
    Citro V; Cimmaruta C; Monticelli M; Riccio G; Hay Mele B; Cubellis MV; Andreotti G
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphomannose isomerase inhibitors improve N-glycosylation in selected phosphomannomutase-deficient fibroblasts.
    Sharma V; Ichikawa M; He P; Scott DA; Bravo Y; Dahl R; Ng BG; Cosford ND; Freeze HH
    J Biol Chem; 2011 Nov; 286(45):39431-8. PubMed ID: 21949237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposome-encapsulated mannose-1-phosphate therapy improves global N-glycosylation in different congenital disorders of glycosylation.
    Budhraja R; Radenkovic S; Jain A; Muffels IJJ; Ismaili MHA; Kozicz T; Pandey A; Morava E
    Mol Genet Metab; 2024 Jun; 142(2):108487. PubMed ID: 38733638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A frequent mild mutation in ALG6 may exacerbate the clinical severity of patients with congenital disorder of glycosylation Ia (CDG-Ia) caused by phosphomannomutase deficiency.
    Westphal V; Kjaergaard S; Schollen E; Martens K; Grunewald S; Schwartz M; Matthijs G; Freeze HH
    Hum Mol Genet; 2002 Mar; 11(5):599-604. PubMed ID: 11875054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mannose supplementation in PMM2-CDG.
    Taday R; Park JH; Grüneberg M; DuChesne I; Reunert J; Marquardt T
    Orphanet J Rare Dis; 2021 Aug; 16(1):359. PubMed ID: 34380532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Basis of the Molecular Switch between Phosphatase and Mutase Functions of Human Phosphomannomutase 1 under Ischemic Conditions.
    Ji T; Zhang C; Zheng L; Dunaway-Mariano D; Allen KN
    Biochemistry; 2018 Jun; 57(25):3480-3492. PubMed ID: 29695157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mouse model of a human congenital disorder of glycosylation caused by loss of PMM2.
    Chan B; Clasquin M; Smolen GA; Histen G; Powe J; Chen Y; Lin Z; Lu C; Liu Y; Cang Y; Yan Z; Xia Y; Thompson R; Singleton C; Dorsch M; Silverman L; Su SM; Freeze HH; Jin S
    Hum Mol Genet; 2016 Jun; 25(11):2182-2193. PubMed ID: 27053713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Congenital disorder of glycosylation type Ia (CDG Ia) - underdiagnosed entity?].
    Sätilä H; Kuusela AL; Pietilä K; Niinikoski H; Keskinen P
    Duodecim; 2016; 132(3):253-9. PubMed ID: 26951030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yeast Models of Phosphomannomutase 2 Deficiency, a Congenital Disorder of Glycosylation.
    Lao JP; DiPrimio N; Prangley M; Sam FS; Mast JD; Perlstein EO
    G3 (Bethesda); 2019 Feb; 9(2):413-423. PubMed ID: 30530630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New and potential strategies for the treatment of PMM2-CDG.
    Gámez A; Serrano M; Gallego D; Vilas A; Pérez B
    Biochim Biophys Acta Gen Subj; 2020 Nov; 1864(11):129686. PubMed ID: 32712172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Chaperoning: A Potential Treatment for PMM2-CDG.
    Yuste-Checa P; Brasil S; Gámez A; Underhaug J; Desviat LR; Ugarte M; Pérez-Cerdá C; Martinez A; Pérez B
    Hum Mutat; 2017 Feb; 38(2):160-168. PubMed ID: 27774737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary ovarian insufficiency in a female with phosphomannomutase-2 gene (PMM2) mutations for congenital disorder of glycosylation.
    Masunaga Y; Mochizuki M; Kadoya M; Wada Y; Okamoto N; Fukami M; Kato F; Saitsu H; Ogata T
    Endocr J; 2021 May; 68(5):605-611. PubMed ID: 33583911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG.
    Iyer S; Sam FS; DiPrimio N; Preston G; Verheijen J; Murthy K; Parton Z; Tsang H; Lao J; Morava E; Perlstein EO
    Dis Model Mech; 2019 Nov; 12(11):. PubMed ID: 31636082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphomannomutase deficiency (PMM2-CDG): ataxia and cerebellar assessment.
    Serrano M; de Diego V; Muchart J; Cuadras D; Felipe A; Macaya A; Velázquez R; Poo MP; Fons C; O'Callaghan MM; García-Cazorla A; Boix C; Robles B; Carratalá F; Girós M; Briones P; Gort L; Artuch R; Pérez-Cerdá C; Jaeken J; Pérez B; Pérez-Dueñas B
    Orphanet J Rare Dis; 2015 Oct; 10():138. PubMed ID: 26502900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary mannose supplementation in phosphomannomutase 2 deficiency (PMM2-CDG).
    Taday R; Grüneberg M; DuChesne I; Reunert J; Marquardt T
    Orphanet J Rare Dis; 2020 Sep; 15(1):258. PubMed ID: 32962735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.